치자 추출물이 RANKL 유도 파골세포 형성 및 골 흡수에 미치는 영향
Effects of Gardeniae Jasminoides on RANKL-induced Osteoclastogenesis and Bone Resorption
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: This study was performed to investigate the effects of Gardenia jasminoides extract (GJ) on osteoclast differentiation and bone resorption in vitro. Methods: To investigate the effect of GJ on osteoclast differentiation, the mouse leukemic myeloid cell line RAW 264.7 was stimulated by RANKL (receptor activator of nuclear factor kB ligand). Osteoclast differentiation was measured by counting TRAP (+) MNC in the presence of RANKL. To elucidate the mechanism of the inhibitory effect of GJ on osteoclast differentiation, gene expression of TRAP, Cathepsin K, MMP-9, NFATc1, c-Fos, MITF, DC-STAMP, CTR, OC-STAMP and Atp6v0d2 was measured using reverse transcription-PCR (RT-PCR). Bone resorption was measured using the bone pit formation assay. Results: GJ decreased the number of TRAP (+) MNCs in the presence of RANKL. GJ inhibited the expression of cathepsin K, MMP-9, TRAP, MITF, NFATc1, c-Fos, iNON, OC-STAMP, Atp6v0d2, and DC-STAMP in the osteoclast, and inhibited bone pit formation in vitro. Conclusions: The results suggest that GJ has inhibitory effects on bone resorption resulting from inhibition of osteoclast differentiation and gene expression.
Abstract
Objectives: This study was performed to investigate the effects of Gardenia jasminoides extract (GJ) on osteoclast differentiation and bone resorption in vitro. Methods: To investigate the effect of GJ on osteoclast differentiation, the mouse leukemic myeloid cell line RAW 264.7 was stimulated by RANKL (receptor activator of nuclear factor kB ligand). Osteoclast differentiation was measured by counting TRAP (+) MNC in the presence of RANKL. To elucidate the mechanism of the inhibitory effect of GJ on osteoclast differentiation, gene expression of TRAP, Cathepsin K, MMP-9, NFATc1, c-Fos, MITF, DC-STAMP, CTR, OC-STAMP and Atp6v0d2 was measured using reverse transcription-PCR (RT-PCR). Bone resorption was measured using the bone pit formation assay. Results: GJ decreased the number of TRAP (+) MNCs in the presence of RANKL. GJ inhibited the expression of cathepsin K, MMP-9, TRAP, MITF, NFATc1, c-Fos, iNON, OC-STAMP, Atp6v0d2, and DC-STAMP in the osteoclast, and inhibited bone pit formation in vitro. Conclusions: The results suggest that GJ has inhibitory effects on bone resorption resulting from inhibition of osteoclast differentiation and gene expression.
참고문헌 (27)
- Kling JM, "Osteoporosis prevention, screening, and treatment: a review", J Womens Health, 23(7), pp.563~572 (2014)
- Sweet MG, "Diagnosis and treatment of osteoporosis", Am Fam Physician, 79(3), pp.193~200 (2009)
- 박진희, "Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation", Molecules and Cells, 40(10), pp.706~713 (2017), 한국분자세포생물학회[DOI]
- Miyamoto T, "Differentiation and function of osteoclasts", Keio J Med, 52(1), pp.1~7 (2003)
- 김정하, "Regulation of NFATc1 in Osteoclast Differentiation", 대한골대사학회지, 21(4), pp.233~241 (2014), 대한골대사학회[DOI]
- Jeong BS, "Do-hae Hyang-yak(Saeng-yak)Dae-sajeon", pp.925~926 (1990), Young-lim-sa
- Yu Y, "Chemical constituents from the fruits of Gardenia jasminoides Ellis", Fitoterapia, 83(3), pp.563~567 (2012)
- Oshima T, "Determination of geniposide, gardenoside, geniposidic acid and genipin-1-beta -gentiobioside in Gardenia jasminoides by highperformance liquid chromatography", J Chromatogr, 455, pp.410~414 (1988)
- Sung YY, "The Gardenia jasminoides extract and its constituent, geniposide, elicit anti-allergic effects on atopic dermatitis by inhibiting histamine in vitro and in vivo", J Ethnopharmacol, 156, pp.33~40 (2014)
- Chen YH, "Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile ductligated rats and human hepatic stellate cells", World J Gastroenterol, 18(48), pp.7158~7165 (2012)
- Akihisa T, "Melanogenesis inhibitory activity of monoterpene glycosides from Gardeniae Fructus", Chem Biodivers, 9(8), pp.1490~1499 (2012)
- Zhang HY, "Antithrombotic activities of aqueous extract from Gardenia jasminoides and its main constituent", Pharm Biol, 51(2), pp.221~225 (2013)
- Lee JH, "Gardenia jasminoides Ellis ethanol extract and its constituents reduce the risks of gastritis and reverse gastric lesions in rats", Food Chem Toxicol, 47(6), pp.1127~1131 (2009)
- Wang L, "Targeted metabolome profiling by dual-probe microdialysis sampling and treatment using Gardenia jasminoides for rats with type 2 diabetes", Sci Rep, 7(1), pp.1010~1015 (2017)
- Zhang H, "Learning and memory improvement and neuroprotection of Gardenia jasminoides (Fructus gardenia) extract on ischemic brain injury rats", J Ethnopharmacol, 196, pp.225~235 (2017)
- Im M, "Ethanol extract of baked Gardeniae Fructus exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells: Role of suppression of the NF-κB and HIF-1α pathways", Int J Oncol, 49(6), pp.2377~2386 (2016)
- Atkins GJ, "Osteocyte regulation of bone mineral: a little give and take", Osteoporos Int, 23(8), pp.2067~2079 (2012)
- Drake MT, "Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned", Endocr Rev, 38(4), pp.325~350 (2017)
- 김진희, "Cordyceps militaris Mushroom and Cordycepin Inhibit RANKL-Induced Osteoclast Differentiation", Journal of Medicinal Food, 18(4), pp.446~452 (2015), 한국식품영양과학회[DOI]
- Fong D, "Bone morphogenetic protein-9 activates Smad and ERK pathways and supports human osteoclast function and survival in vitro", Cell Signal, 25(4), pp.717~728 (2013)
- Kim J, "Inhibitory effect of brazilin on osteoclast differentiation and its mechanism of action", Int Immunopharmacol, 29(2), pp.628~634 (2015)
- Lu SY, "MITF regulates osteoclastogenesis by modulating NFATc1 activity", Exp Cell Res, 328(1), pp.32~43 (2014)
- Park SH, "Protocatechuic Acid Attenuates Osteoclastogenesis by Downregulating JNK", c-Fos, Phytother Res, pp.2016, 30(4)[DOI]
- Zeng XZ, "Aconine inhibits RANKL -induced osteoclast differentiation in RAW264.7cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression", Acta Pharmacol Sin, 37(2), pp.255~263 (2016)
- Song J, "α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced)Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways", Med Sci Monit, 23, pp.5056~5069 (2017)
- Korbecki J, "Cyclooxygenase pathways", Acta Biochim Pol, 61(4), pp.639~649 (2014)
- Laveti D, "Anti-inflammatory treatments for chronic diseases: a review", Inflamm Allergy Drug Targets, 12(5), pp.349~361 (2013)